SCHEMBL6232931

SCHEMBL6232931

Cn1c(Cl)nc2ccc(N)cc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.58
KDM4E B2RXH2 6/20 0.44
NPC1 O15118 6/20 0.44
ALDH1A1 P00352 5/20 0.44
RAB9A P51151 5/20 0.44
GAA P10253 4/20 0.44
HSD17B10 Q99714 3/20 0.44
TP53 P04637 3/20 0.44
PKM P14618 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPT P10636 6/20 0.41
NSD2 O96028 1/20 0.41
BRPF1 P55201 2/20 0.40
POLB P06746 3/20 0.39
LMNA P02545 1/20 0.39
CASP6 P55212 1/20 0.39
PRKCI P41743 1/20 0.39
KMT2A Q03164 3/20 0.39
TSHR P16473 1/20 0.39
HPGD P15428 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6230772 0.85 SMN1; SMN2 (0.58) SMN1; SMN2KDM4ENPC1ALDH1A1RAB9A
SCHEMBL18965901 0.81 KDM4E (0.43) SMN1; SMN2KDM4ENPC1ALDH1A1RAB9A
SCHEMBL521102 0.79 KDM4E (0.55) SMN1; SMN2KDM4ENPC1ALDH1A1RAB9A
SCHEMBL31473995 0.78 SMN1; SMN2 (0.58) SMN1; SMN2NPC1ALDH1A1RAB9ATP53
SCHEMBL4539855 0.78 SMN1; SMN2 (0.58) SMN1; SMN2KDM4ENPC1ALDH1A1RAB9A
SCHEMBL17674019 0.78 SMN1; SMN2 (0.58) SMN1; SMN2NPC1ALDH1A1RAB9ATP53
SCHEMBL2634929 0.78 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AKMT2AMEN1
SCHEMBL20982581 0.76 KDM4E (0.68) SMN1; SMN2KDM4ENPC1ALDH1A1RAB9A
SCHEMBL23679807 0.76 SMN1; SMN2 (0.55) SMN1; SMN2KDM4ENPC1ALDH1A1RAB9A
SCHEMBL6592993 0.75 MCHR1 (0.39) SMN1; SMN2KDM4ENPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005035526-A1 BICYCLIC COMPOUNDS AND THEIR THERAPEUTIC USE ARGENTA DISCOVERY LTD. (GB) 2005-04-21 WO disclosed
WO-2004092181-A9 HETEROCYCLIC MCHR1 ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2005-01-27 WO disclosed